Inventor · disambiguated record
Sambaiah Thota
Also filed as: THOTA SAMBAIAH
45 granted patents·4 pending applications·547 citations·filing 2003–2021
98Inventor score
Top patents by PatentIndex Score
49 records- 0197US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 0297US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0396US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 0496US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 0596US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 0696US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 0795US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 0895US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 0995US8193197B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Jun 5, 2012·17 cites·38 claims
- 1094US7868013B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 11, 2011·25 cites·12 claims
- 1193US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 1292US9889103B2Method for the preparation of N-acetyl cysteine amideNACUITY PHARMACEUTICALS INC·Filed 2017·Granted Feb 13, 2018·8 cites·20 claims
- 1392US9763902B2Method for preparation of N-acetyl cysteine amideNACUITY PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·8 cites·20 claims
- 1491US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 1591US8309566B2Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinasesBHAMIDIPATI SOMASEKHAR·Filed 2009·Granted Nov 13, 2012·17 cites·26 claims
- 1691US8119809B2AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the sameHONG HUI·Filed 2008·Granted Feb 21, 2012·17 cites·27 claims
- 1790US8304422B2Compositions and methods for inhibition of the JAK pathwayATUEGBU ANDY·Filed 2010·Granted Nov 6, 2012·26 cites·22 claims
- 1889US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 1989US8569340B2AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the sameHONG HUI·Filed 2012·Granted Oct 29, 2013·12 cites·27 claims
- 2089US8410093B2Cycloalkyl substituted pyrimidinediamine compounds and their usesLI HUI·Filed 2010·Granted Apr 2, 2013·9 cites·20 claims
- 2188US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 2287US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 2387US9725419B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·7 cites·3 claims
- 2486US8129390B2Carboxamide, sulfonamide and amine compounds and methods for using the sameDARWISH IHAB S·Filed 2008·Granted Mar 6, 2012·9 cites·53 claims
- 2586US8012955B2N-substituted-heterocycloalkyloxybenzamide compounds and methods of useRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Sep 6, 2011·7 cites·70 claims
- 2686US7569580B2Heterotricyclic compounds for use as HCV inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Aug 4, 2009·6 cites·11 claims
- 2785US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 2885US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
- 2981US9593082B2Compositions and methods for inhibition of the JAK pathwayARGADE ANKUSH·Filed 2008·Granted Mar 14, 2017·3 cites·17 claims
- 3080US11827628B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·19 claims
- 3179US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 3274US8557822B2Carboxamide, sulfonamide and amine compounds and methods for using the sameDARWISH IHAB S·Filed 2012·Granted Oct 15, 2013·2 cites·51 claims
- 3371US9174964B2AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·1 cites·23 claims
- 3471US8697727B2N-substituted-heterocycloalkyloxybenzamide compounds and methods of useSINGH RAJINDER·Filed 2011·Granted Apr 15, 2014·1 cites·26 claims
- 3570US11667611B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 3668US9040543B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·0 cites·17 claims
- 3766US8278299B2Pyrimidinediamine kinase inhibitorsSINGH RAJINDER·Filed 2009·Granted Oct 2, 2012·0 cites·37 claims
- 3862US9040527B2Pyrimidinediamine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2013·Granted May 26, 2015·0 cites·11 claims
- 3962US2007203161A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4061US9624229B2Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinasesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Apr 18, 2017·0 cites·8 claims
- 4160US8729087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2012·Granted May 20, 2014·0 cites·22 claims
- 4259US9181220B2N-substituted-heterocycloalkyloxybenzamide compounds and methods of useRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·0 cites·24 claims
- 4359US2017121291A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4458US8895578B2Carboxamide, sulfonamide and amine compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Nov 25, 2014·0 cites·37 claims
- 4555US8518937B2Pyrimidinediamine kinase inhibitorsSINGH RAJINDER·Filed 2012·Granted Aug 27, 2013·0 cites·19 claims
- 4651US7358259B2HCV inhibitors and methods of using themRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Apr 15, 2008·0 cites·18 claims
- 4750US2007149520A1HCV Inhibitors And Methods Of Using ThemRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4845US2005215614A1Substituted indoles and their use as hcv inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4932US10047089B2Dihydro-6-azaphenalene derivatives for the treatment of CNS, oncological diseases and related disordersCOLLABORATIVE MEDICINAL DEV LLC·Filed 2013·Granted Aug 14, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Sambaiah Thota files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →